1227801

Gilead Sciences, Inc. — FEI 1000523075

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 22, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Foster City, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report